Clincosm LogoSign in Get a demo

ALLMED: Alleged Drug Allergies in Military General Medicine: Patients' Experiences and Beliefs

Sponsor
Direction Centrale du Service de Santé des Armées (Other)
Overall Status
Recruiting
CT.gov ID
NCT06112470
Collaborator
(none)
20
Enrollment
1
Location
12.1
Anticipated Duration (Months)
1.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study focuses on the experience of the military patient reporting a suspected drug allergy, with its own specificities. Suspicions of drug allergies during a mission expose the doctor to difficulties.

This study will improve understanding of the allergy patient's point of view. The end result could be a set of ideas for measures to raise awareness among these patients, and motivate them to undergo an allergological assessment.

Condition or Disease Intervention/Treatment Phase
  • Other: Interview

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Alleged Drug Allergies in Military General Medicine: Patients' Experiences and Beliefs (ALLMED)
Actual Study Start Date :
Feb 28, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Interview

Monocentric qualitative study with a descriptive socio-demographic section, a descriptive qualitative section on the experience and perception of allergy, then on the obstacles to allergological assessment, and finally a descriptive quantitative section to evaluate knowledge of antibiotic therapy.

Other: Interview
Semi-structured interview on experiences, perceptions, beliefs and knowledge of drug allergy and barriers to allergological testing, with a view to content analysis.

Outcome Measures

Primary Outcome Measures

  1. Patients' experiences of drug allergies [Through study completion (12 months)]

    describe patients' experiences, perceptions, beliefs and knowledge of drug allergies in general practice in the army

Secondary Outcome Measures

  1. Patients' obstacles [Through study completion (12 months)]

    describe the obstacles to allergological assessment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • Military personnel (active or reservist)

  • Reporting a drug allergy during a periodic medical check-up or during a consultation in a medical unit

  • Not opposed to participating in the study.

Exclusion Criteria:

  • Candidate on admission visit

  • Opposition to study

  • Minor (under 18 years of age)

  • Pregnant, parturient or breast-feeding woman

  • Person deprived of liberty by a judicial or administrative decision, person under psychiatric care

  • Non-French nationals

  • Person of full age subject to a legal protection measure

  • Person unable to express non-opposition

Contacts and Locations

Locations

Site City State Country Postal Code
1 15ème antenne médicale - Camp des Matelots Versailles France 78013

Sponsors and Collaborators

  • Direction Centrale du Service de Santé des Armées

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Direction Centrale du Service de Santé des Armées
ClinicalTrials.gov Identifier:
NCT06112470
Other Study ID Numbers:
  • 2022PPRC02
First Posted:
Nov 1, 2023
Last Update Posted:
Nov 1, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Hypersensitivity
Drug Hypersensitivity

Study Results

No Results Posted as of Nov 1, 2023